- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02400684
ENDmetriosis and Reserve Ovarienne (ENDRO)
Endometriosis is the ectopic implantation of endometrial glands and stroma, and can be ovarian and peritoneal (superficial or deep). There are 4 stages in endometriosis according to severity, and the stage is established on the basis of intra-operative observations. The AFSr classification is currently most used (I-IV,minimal, mild, moderate, severe). Most associated with endometriosis are subfertility and pelvic pain.
In the surgical management of deep endometriosis, the issue of fertility is pivotal. There is a higher rate of infertility in a population of women with endometriosis as compared to the general population, even though the mechanisms are not yet elucidated. Patients with deep endometriosis can be referred to the surgeon for subfertility, but even when they are referred for chronic pain, future fertility considerations are taken into account in the planning of the surgery, as the patients are often young.
It is now well documented that ovarian cystectomy is deleterious with regards to the ovarian reserve, and more so in endometriomas than in any other type of benign cysts. The ovarian reserve is the functional potential of the ovaries, reflecting the quantity and quality of remaining follicles. Studies have also relied greatly on the measure of serum anti-mullerian hormone (AMH) to evaluate the effect of cystectomy on ovarian reserve, as AMH is currently the most reliable marker to assess ovarian reserve. A significant difference was found between AMH before and following cystectomy in several studies. The deleterious effect of deep endometriosis surgery which comprises a wide dissection and adhesiolysis of the pelvis in many cases, even when no cystectomy has been performed, is therefore not entirely ruled out. To the best of our knowledge, there are no studies on the effect of deep endometriosis surgery, apart from ovarian surgery, on ovarian reserve.
Our center is very active in the laparoscopic surgical treatment of deep endometriosis, with more than 200 cases every year. The objective of this trial is to assess the effect of deep endometriosis surgery on the ovarian reserve, whether a cystectomy is performed or not, by measuring serum AMH before and after surgery, at 6 months and 1 year post-operatively.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Schiltigheim, France, 67303
- CMCO - Hôpitaux Universitaires de Strasbourg
-
Strasbourg, France, 67200
- Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- female patient between 18 and 38 years
- endometriosis stage III or IV in the AFSr classification
- laparoscopy included deep endometriosis procedures (adhesiolysis, ureterolysis, cystectomy, resection of bowel, urinary or deep peritoneal endometriosis)
- written informed consent
Exclusion Criteria:
- previous adnexectomy or adnexectomy during surgery
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Deep endometriosis
The population is a female population, above 18 years and under 38 years who have stage III or IV endometriosis (which will remain to be confirmed after inclusion by intra-operative observations), and who undergo operative laparoscopy in our center, with only deep endometriosis without endometriomas.
|
Evolution of AMH before and after deep endometriosis surgery
|
|
Deep endometriosis and endométriomas
The population is a female population, above 18 years and under 38 years who have stage III or IV endometriosis (which will remain to be confirmed after inclusion by intra-operative observations), and who undergo operative laparoscopy in our center, with deep endometriosis and endometriomas.
|
Evolution of AMH before and after deep endometriosis surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in ovarian reserve (determined by AMH) at one year
Time Frame: Baseline : before surgery (less than one month) and one year after surgery
|
Baseline : before surgery (less than one month) and one year after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percentage of decline in AMH between patients who underwent ovarian cystectomy and those who did not
Time Frame: baseline and 1 year after surgery
|
baseline and 1 year after surgery
|
|
Evolution curve of AMH at 6 months and 1 year post-operatively
Time Frame: baseline, 6 months and 1 year after surgery
|
baseline, 6 months and 1 year after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Catherine RONGIERES, MD, Hôpitaux Universitaires de Strasbourg
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Endometriosis Stage III
-
Shenzhen Second People's HospitalRecruiting
-
Simone FerreroCompletedEndometriosis | Deep EndometriosisItaly
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...RecruitingEndometriosis | Deep Endometriosis | Ovarian Endometrioma | Bowel EndometriosisItaly
-
University Hospital MuensterCompletedEndometriosis | Complication | Deep Endometriosis | Reproductive Issues | Bowel EndometriosisGermany
-
Medical University of ViennaDepartment of Obstetrics and Gynaecology, Insubria Unievrsity, Varese (Italy)UnknownDeep Infiltrating Endometriosis
-
IpsenCompletedDeep Infiltrating Endometriosis (DIE)China
-
Oslo University HospitalSt John of God Hospital, Vienna; Nepean Blue Mountains Local Health DistrictCompletedQuality of Life | Pain, Chronic | Deep Endometriosis | Bowel Dysfunction | Endometriosis Related Pain | Endometriosis Rectum | Deep Infiltrating EndometriosisNorway, Australia, Austria
-
Hospices Civils de LyonRecruitingDeep Infiltrating EndometriosisFrance
-
University Hospital, Clermont-FerrandLaboratoire SERB; Association GEGOUnknownDeep Endometriosis | Recto Vaginal NodeFrance
-
Baylor College of MedicineNot yet recruitingEndometriosis (Diagnosis) | Ureteral Injury | Endometriosis Pelvic | Indocyanine Green (ICG) | Ureteral Stent Placement | Endometriosis Ovaries | Robotic Surgical Procedure | Deep Infiltrating Endometriosis (DIE) | Endometriosis of the Cul-de-sacUnited States
Clinical Trials on blood samples
-
Centre Georges Francois LeclercINSERM U866 Faculté de Médecine et PharmacieCompleted
-
Centre Hospitalier Universitaire DijonCompletedPrimary Immune Thrombocytopenia (ITP)France
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPaediatric MalignanciesFrance
-
Centre Hospitalier Universitaire DijonCompleted
-
Assistance Publique Hopitaux De MarseilleRecruitingPlastic SurgeriesFrance
-
Assiut UniversityCompleted
-
Ain Shams UniversityCompletedUrinary Tract Infection Bacterial | Pneumonia - Bacterial | All Conditions Causing SepsisEgypt
-
University Hospital, AngersRecruiting
-
Centre Hospitalier Universitaire DijonRecruiting
-
Assistance Publique Hopitaux De MarseilleRecruitingLeukaemia During Childhood or AdolescenceFrance